Stockreport

Nasus Pharma Announces Closing of $15.0 Million Private Placement

Nasus Pharma Ltd. Ordinary Shares  (NSRX) 
PDF TEL AVIV, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus Pharma" or the "Company"), a clinical-stage pharmaceutical company focused on the de [Read more]